The Association Between Metabolic Syndrome and Colorectal Cancer Risk by Obesity Status in Korean Women: A Nationwide Cohort Study
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: This study aimed to determine the association between metabolic syndrome (MetS) and the incidence of colorectal cancer (CRC) in Korean women with obesity. Methods: Cancer-free women (n=6 142 486) aged 40-79 years, who underwent National Health Insurance Service health examinations in 2009 and 2010 were included. The incidence of CRC was followed until 2018. The hazard ratio (HR) of MetS for the incidence of colon and rectal cancer was analyzed according to body mass index (BMI) categories, adjusting for confounders such as women’s reproductive factors. In addition, the heterogeneity of associations across BMI categories was assessed. Results: Women with MetS were at increased risk of colon and rectal cancer compared to women without MetS (HR, 1.20; 95% confidence interval [CI], 1.16 to 1.23 and HR,1.15; 95% CI, 1.11 to 1.20), respectively. The HR of MetS for colon cancer across BMI categories was 1.12 (95% CI, 1.06 to 1.19), 1.14 (95% CI, 1.08 to 1.20), and 1.16 (95% CI, 1.12 to 1.21) in women with BMIs <23.0 kg/m2, 23.0- 24.9 kg/m2, and ≥25.0 kg/m2, respectively. The HR of MetS for rectal cancer across corresponding BMI categories was 1.16 (95% CI, 1.06 to 1.26), 1.14 (95% CI, 1.05 to 1.23), and 1.13 (95% CI, 1.06 to 1.20). The heterogeneity of associations across BMI categories was not significant in either colon or rectal cancer (p=0.587 for colon cancer and p=0.927 for rectal cancer). Conclusions: Women with MetS were at increased risk of colon and rectal cancer. Clinical and public health strategies should be considered for primary CRC prevention with an emphasis on improving women’s metabolic health across all BMI groups.
Abstract
Objectives: This study aimed to determine the association between metabolic syndrome (MetS) and the incidence of colorectal cancer (CRC) in Korean women with obesity. Methods: Cancer-free women (n=6 142 486) aged 40-79 years, who underwent National Health Insurance Service health examinations in 2009 and 2010 were included. The incidence of CRC was followed until 2018. The hazard ratio (HR) of MetS for the incidence of colon and rectal cancer was analyzed according to body mass index (BMI) categories, adjusting for confounders such as women’s reproductive factors. In addition, the heterogeneity of associations across BMI categories was assessed. Results: Women with MetS were at increased risk of colon and rectal cancer compared to women without MetS (HR, 1.20; 95% confidence interval [CI], 1.16 to 1.23 and HR,1.15; 95% CI, 1.11 to 1.20), respectively. The HR of MetS for colon cancer across BMI categories was 1.12 (95% CI, 1.06 to 1.19), 1.14 (95% CI, 1.08 to 1.20), and 1.16 (95% CI, 1.12 to 1.21) in women with BMIs <23.0 kg/m2, 23.0- 24.9 kg/m2, and ≥25.0 kg/m2, respectively. The HR of MetS for rectal cancer across corresponding BMI categories was 1.16 (95% CI, 1.06 to 1.26), 1.14 (95% CI, 1.05 to 1.23), and 1.13 (95% CI, 1.06 to 1.20). The heterogeneity of associations across BMI categories was not significant in either colon or rectal cancer (p=0.587 for colon cancer and p=0.927 for rectal cancer). Conclusions: Women with MetS were at increased risk of colon and rectal cancer. Clinical and public health strategies should be considered for primary CRC prevention with an emphasis on improving women’s metabolic health across all BMI groups.
참고문헌 (34)
- Bellastella G, "Metabolic syndrome and cancer: “the common soil hypothesis”", Diabetes Res Clin Pract, 143, pp.389~397 (2018)
- Blüher M, "Metabolically healthy obesity", Endocr Rev, 41(3), pp.bnaa004~ (2020)
- Smith GI, "Metabolically healthy obesity : facts and fantasies", J Clin Invest, 129(10), pp.3978~3989 (2019)
- GBD 2019 Colorectal Cancer Collaborators, "Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019", Lancet Gastroenterol Hepatol, 7(7), pp.627~647 (2022)
- Shen X, "Metabolic syndrome and the risk of colorectal cancer : a systematic review and meta-analysis", Int J Colorectal Dis, 36(10), pp.2215~2225 (2021)
- Ma Y, "Obesity and risk of colorectal cancer : a systematic review of prospective studies", PLoS One, 8(1), pp.e53916~ (2013)
- Goodarzi G, "Metabolic phenotypes and risk of colorectal cancer : a systematic review and meta-analysis of cohort studies", BMC Cancer, 22(1), pp.89~ (2022)
- Choi YJ, "Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer", Eur J Epidemiol, 33(11), pp.1077~1085 (2018)
- Tran TT, "Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study", Cancer, 128(6), pp.1230~1241 (2022)
- Jin EH, "Association between metabolic syndrome and the risk of colorectal cancer diagnosed before age 50 years according to tumor location", Gastroenterology, 163(3), pp.637~648.e2 (2022)
- 고슬기, "Metabolic Risk Profile and Cancer in Korean Men and Women", 예방의학회지, 49(3), pp.143~152 (2016), 대한예방의학회
- Fuhrman BJ, "Association of the age at menarche with site-specific cancer risks in pooled data from nine cohorts", Cancer Res, 81(8), pp.2246~2255 (2021)
- Lin KJ, "The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer", Int J Cancer, 130(2), pp.419~430 (2012)
- Bosetti C, "Oral contraceptives and colorectal cancer risk : a systematic review and meta-analysis", Hum Reprod Update, 15(5), pp.489~498 (2009)
- Lee J, "Cohort profile : the National Health Insurance Service-National Sample Cohort(NHIS-NSC), South Korea", Int J Epidemiol, 46(2), pp.e15~ (2017)
- Grundy SM, "Diagnosis and management of the metabolic syndrome. An American Heart Association", National Heart, Lung, and Blood Institute Scientific Statement. Executive summary, 2005, pp.13(6), 322~327
- "The Asia-Pacific perspective: redefining obesity and its treatment" (2000)[URL]
- "2022 National Health Insurance & long-term care insurance system in Republic of Korea" (2000)[URL]
- 양민수, "Validation of Cancer Diagnosis Based on the National Health Insurance Service Database versus the National Cancer Registry Database in Korea", Cancer Research and Treatment, 54(2), pp.352~361 (2022), 대한암학회[DOI]
- Bouras E, "Endogenous sex steroid hormones and colorectal cancer risk : a systematic review and meta-analysis", Discov Oncol, 12(1), pp.8~ (2021)
- Mørch LS, "The influence of hormone therapies on colon and rectal cancer", Eur J Epidemiol, 31(5), pp.481~489 (2016)
- Iacopetta B, "Are there two sides to colorectal cancer?", Int J Cancer, 101(5), pp.403~408 (2002)
- van der Sijp MP, "Differences between colon and rectal cancer in complications, short-term survival and recurrences", Int J Colorectal Dis, 31(10), pp.1683~1691 (2016)
- de Kort S, "Diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women : results from the Netherlands Cohort Study on diet and cancer", Eur J Gastroenterol Hepatol, 28(8), pp.896~903 (2016)
- Murphy G, "Sex disparities in colorectal cancer incidence by anatomic subsite, race and age", Int J Cancer, 128(7), pp.1668~1675 (2011)
- Bufill JA, "Colorectal cancer : evidence for distinct genetic categories based on proximal or distal tumor location", Ann Intern Med, 113(10), pp.779~788 (1990)
- Shin A, "Site-specific risk factors for colorectal cancer in a Korean population", PLoS One, 6(8), pp.e23196~ (2011)
- Tian Y, "The association between serum lipids and colorectal neoplasm : a systemic review and meta-analysis", Public Health Nutr, 18(18), pp.3355~3370 (2015)
- Yang Z, "Relationship between serum lipid level and colorectal cancer : a systemic review and meta-analysis", BMJ Open, 12(6), pp.e052373~ (2022)
- O’Neill S, "Metabolic syndrome : a closer look at the growing epidemic and its associated pathologies", Obes Rev, 16(1), pp.1~12 (2015)
- Murphy N, "Circulating levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 associate with risk of colorectal cancer based on serologic and mendelian randomization analyses", Gastroenterology, 158(5), pp.1300~1312.e20 (2020)
- Cho YK, "Metabolic health is a determining factor for incident colorectal cancer in the obese population : a nationwide population-based cohort study", Cancer Med, 10(1), pp.220~229 (2021)
- Farvid MS, "Consumption of red meat and processed meat and cancer incidence : a systematic review and meta-analysis of prospective studies", Eur J Epidemiol, 36(9), pp.937~951 (2021)
- Seong SC, "Data resource profile : the National Health Information Database of the National Health Insurance Service in South Korea", Int J Epidemiol, 46(3), pp.799~800 (2017)